Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis

Autoimmunity

Volumn 47, Issue 6, 2014, Pages 383-388

  Cheng, Fa Juan ^a,b,c   Zhou, Xu Jie ^a,b,c   Zhao, Yan Feng ^a,b,c   Zhao, Ming Hui ^a,b,c   Zhang, Hong ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c Ministry of Education   (China)

Author keywords

Chinese Han ethnicity; Complex autoimmune disease; Functional genetic variant; Susceptibility; Systemic lupus erythematosus

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CCR5 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CHEMOKINE RECEPTOR CCR5 GENE; CHINESE; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; GENE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PUBLISHING; SENSITIVITY ANALYSIS; CHINA; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; LUPUS NEPHRITIS; POLYMORPHISM, GENETIC; RECEPTORS, CCR5;

EID: 84906541161     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.906581     Document Type: Article

References (46)

1. Ortega, L. M., D. R. Schultz, O. Lenz, et al. 2010. Review: Lupus nephritis: Pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19: 557-574
2. Zhou, X. J., J. C. Lv, W. R. Cheng, et al. 2010. Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. Clin. Exp. Rheumatol. 28: 397-400
3. Yang, X. W., Y. Tan, F. Yu, and M. H. Zhao. 2012. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Hum. Immunol. 73: 156-163
4. Nowling, T. K., and G. S. Gilkeson. 2011. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 13: 250
5. Sjowall, C., A. I. Olin, T. Skogh, et al. 2013. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Autoimmunity 46: 205-214
6. Loetscher, P., M. Uguccioni, L. Bordoli, et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345
7. Mack, M., J. Cihak, C. Simonis, et al. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166: 4697-4704
8. Raport, C. J., J. Gosling, V. L. Schweickart, et al. 1996. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271: 17161-17166
9. Ruffing, N., N. Sullivan, L. Sharmeen, et al. 1998. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol. 189: 160-168
10. Perez, D. L. G., H. Maier, E. Nieto, et al. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12: 1369-1382
11. Ishikawa, S., T. Sato, M. Abe, et al. 2001. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193: 1393-1402
12. Moore, K. J., T. Wada, S. D. Barbee, and V. R. Kelley. 1998. Gene transfer of RANTES elicits autoimmune renal injury in MRLFas(1pr) mice. Kidney Int. 53: 1631-1641
13. Lloyd, C. M., A. W. Minto, M. E. Dorf, et al. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185: 1371-1380
14. Panzer, U., A. Schneider, J. Wilken, et al. 1999. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 56: 2107-2115
15. Wada, T., K. Furuichi, C. Segawa-Takaeda, et al. 1999. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 56: 995-1003
16. Segerer, S., M. MacK, H. Regele, et al. 1999. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int. 56: 52-64
17. Furuichi, K., T. Wada, N. Sakai, et al. 2000. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am. J. Nephrol. 20: 291-299
18. Chan, R. W., F. M. Lai, E. K. Li, et al. 2006. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton) 11: 219-225
19. Liu, R., W. A. Paxton, S. Choe, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377
20. Aguilar, F., A. Nunez-Roldan, B. Torres, et al. 2003. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774
21. Ye, D., S. Yang, X. Li, et al. 2004. Gene mutation of RANTES and CCR5 in systemic lupus erythematosus. Zhonghua Pifuke Zazhi 37: 18-21
22. Martens, H. A., S. Gross, G. Van Der Steege, et al. 2010. Lack of association of C-C chemokine receptor 5 Delta32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity. J. Rheumatol. 37: 2226-2231
23. Martens, H. A., C. G. Kallenberg, and M. Bijl. 2009. Role of CCR5 Delta32 bp deletion in RA and SLE. Autoimmunity 42: 260-262
24. Turner, J. E., H. J. Paust, S. B. Bennstein, et al. 2012. Protective role for CCR5 in murine lupus nephritis. Am. J. Physiol. Renal Physiol. 302: F1503-F1515
25. Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
26. Weening, J. J., V. D. D'Agati, M. M. Schwartz, et al. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15: 241-250
27. Weening, J. J., V. D. D'Agati, M. M. Schwartz, et al. 2004 The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65: 521-530
28. Chies, J. A., and M. H. Hutz. 2003. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz. J. Med. Biol. Res. 36: 71-75
29. Thakkinstian, A., P. McElduff, C. D'Este, et al. 2005. A method for meta-Analysis of molecular association studies. Stat. Med. 24: 1291-1306
30. Egger, M., S. G. Davey, M. Schneider, and C. Minder. 1997. Bias in meta-Analysis detected by a simple, graphical test. BMJ 315: 629-634
31. Begg, C. B., and M. Mazumdar. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-10101
32. Schauren, J. S., J. A. Marasca, T. D. Veit, et al. 2013. CCR5delta32 in systemic lupus erythematosus: Implications for disease susceptibility and outcome in a Brazilian population. Lupus 22: 802-809
33. Harley, J. B., M. E. Alarcon-Riquelme, L. A. Criswell, et al. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210
34. Han, J. W., H. F. Zheng, Y. Cui, et al. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41: 1234-1237
35. Yang, W., N. Shen, D. Q. Ye, et al. 2010. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6: E1000841
36. Stephens, J. C., D. E. Reich, D. B. Goldstein, et al. 1998. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet. 62: 1507-1515
37. Bodmer, W., and C. Bonilla. 2008. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40: 695-701
38. Kim-Howard, X., A. K. Maiti, J. M. Anaya, et al. 2010. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann. Rheum. Dis. 69: 1329-1332
39. Yang, W., M. Zhao, N. Hirankarn, et al. 2009. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 18: 2063-2070
40. Nath, S. K., S. Han, X. Kim-Howard, et al. 2008. A nonsynonymous functional variant in integrin-Alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40: 152-154
41. Han, S., X. Kim-Howard, H. Deshmukh, et al. 2009. Evaluation of imputation-based association in and around the integrin-Alpha-M (ITGAM) gene and replication of robust association between a nonsynonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum. Mol. Genet. 18: 1171-1180
42. Gomez-Reino, J. J., J. L. Pablos, P. E. Carreira, et al. 1999. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 42: 989-992
43. Buhler, M. M., M. Craig, K. C. Donaghue, et al. 2002. CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort. Autoimmunity 35: 457-461
44. Taylor, K. E., S. A. Chung, R. R. Graham, et al. 2011. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7: E1001311
45. Sanchez, E., A. Nadig, B. C. Richardson, et al. 2011. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann. Rheum. Dis. 70: 1752-1757
46. Morris, D. L., and T. J. Vyse. 2012. Analysis of systemic lupus erythematosus sub-phenotype data for genetic association. Curr. Opin. Rheumatol. 24: 482-488